Meeting
2024 ASCO Annual Meeting
Neoadjuvant immunotherapy for oropharynx cancer: Correlative studies and long-term outcomes from the CIAO trial.
Authors
Daniel McGrail
Cleveland Clinic, Cleveland, OH
Daniel McGrail , Kaiyi Li , Allison Nipper , Faye M. Johnson , Erison Santana , Diana Bell , Minjung Lee , Cara L Haymaker , Adam S. Garden , Shiaw-Yih Lin , J. Jack Lee , Maura L. Gillison , Neil D. Gross , Andrew G. Sikora , Renata Ferrarotto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 6059)
DOI
10.1200/JCO.2024.42.16_suppl.6059
Abstract #
6059
Poster Bd #
375
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
First Author: Robert L. Ferris
Poster
2023 ASCO Annual Meeting
Phase 2 trial of three schedules of CUE-101 administered before surgery or chemoradiotherapy in HLA-A*0201 positive patients with HPV16+ OPSCC.
First Author: Jesse Meir Zaretsky
Poster
2023 ASCO Annual Meeting
Dynamic change of immune phenotype assessed by artificial intelligence (AI)-powered analysis of tumor-infiltrating lymphocytes (TILs) during neoadjuvant durvalumab with or without tremelimumab (D+/-T) in head and neck squamous cell carcinoma (HNSCC).
First Author: Hyunwook Kim
Poster
2023 ASCO Annual Meeting
Circulating tumor DNA dynamics as an early predictor of recurrence in patients with radically resected colorectal cancer: Updated results from GALAXY study in the CIRCULATE-Japan.
First Author: Eiji Oki